The need for noninvasive assessment of cardiac volumes and ejection fraction (EF) ushered
in the use of cardiac imaging techniques in heart failure (HF) trials that investigated the roles …

Heart failure (HF) is one of the most prevalent cardiovascular diseases and is associated
with significant morbidity and a poor prognosis. Since the 1980s, HF phenotyping was …

Introduction Heart failure (HF) is a complex clinical syndrome with diverse risk factors and
etiologies, differing underlying pathophysiology, and large phenotypic heterogeneity …

Imaging modalities stand at the frontiers for progress in congestive heart failure (CHF)
screening, risk stratification and monitoring. Advancements in echocardiography (ECHO) …

Cardiovascular imaging is the cornerstone of the assessment of patients with heart failure.
Although noninvasive volumetric estimation of the cardiac function is an essential and …

Circulating biomarkers and imaging techniques provide independent and complementary
information to guide management of heart failure (HF). This consensus document by the …

Heart failure with preserved ejection fraction (HFpEF) is highly prevalent, affecting
approximately half of all patients with heart failure. 1 It is a significantly heterogeneous …

Heart failure (HF) is a heterogenous disease requiring precise diagnostics and knowledge
of pathophysiological processes. Since structural and functional imaging data are scarce we …

Contemporary clinical trials in heart failure (HF) enroll patients largely based on acuity of
presentation, left ventricular ejection fraction (EF), and functional status. These trial …

Purpose of review The prevalence of heart failure with preserved ejection fraction (HFpEF) is
rising and in some places, it is already the most prevalent form of heart failure. The usual …